NasdaqCM - Delayed Quote USD

23andMe Holding Co. (ME)

0.5131 +0.0036 (+0.71%)
At close: May 24 at 4:00 PM EDT
0.5290 +0.02 (+3.10%)
After hours: May 24 at 7:55 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
247,987.0000
299,489.0000
271,893.0000
243,920.0000
305,463.0000
Cost of Revenue
135,660.0000
164,993.0000
138,948.0000
126,914.0000
168,031.0000
Gross Profit
112,327.0000
134,496.0000
132,945.0000
117,006.0000
137,432.0000
Operating Expense
444,038.0000
458,507.0000
387,098.0000
302,202.0000
351,187.0000
Operating Income
-331,711.0000
-324,011.0000
-254,153.0000
-185,196.0000
-213,755.0000
Net Non Operating Interest Income Expense
15,658.0000
9,676.0000
277.0000
255.0000
6,244.0000
Other Income Expense
-206,493.0000
-93.0000
32,906.0000
1,322.0000
-43,352.0000
Pretax Income
-522,546.0000
-314,428.0000
-220,970.0000
-183,619.0000
-250,863.0000
Tax Provision
-578.0000
-2,772.0000
-3,480.0000
--
--
Net Income Common Stockholders
-521,968.0000
-311,656.0000
-217,490.0000
-183,619.0000
-250,863.0000
Diluted NI Available to Com Stockholders
-521,968.0000
-311,656.0000
-217,490.0000
-183,619.0000
-250,863.0000
Basic EPS
-1.11
-0.69
-0.60
-0.45
-0.62
Diluted EPS
-1.11
-0.69
-0.60
-0.45
-0.62
Basic Average Shares
468,554.4200
451,504.3770
361,528.1190
406,414.8390
406,414.8390
Diluted Average Shares
468,554.4200
451,504.3770
361,528.1190
406,414.8390
406,414.8390
Total Operating Income as Reported
-538,879.0000
-324,011.0000
-254,153.0000
-185,196.0000
-258,447.0000
Total Expenses
579,698.0000
623,500.0000
526,046.0000
429,116.0000
519,218.0000
Net Income from Continuing & Discontinued Operation
-521,968.0000
-311,656.0000
-217,490.0000
-183,619.0000
-250,863.0000
Normalized Income
-315,029.1532
-311,656.0000
-249,819.2200
-183,619.0000
-206,171.0000
Interest Income
15,658.0000
9,676.0000
277.0000
255.0000
--
Net Interest Income
15,658.0000
9,676.0000
277.0000
255.0000
6,244.0000
EBIT
-331,711.0000
-324,011.0000
-254,153.0000
-185,196.0000
-213,755.0000
EBITDA
-299,800.0000
-287,513.0000
-228,005.0000
-164,950.0000
-190,466.0000
Reconciled Cost of Revenue
112,950.0000
150,945.0000
118,386.0000
126,914.0000
168,031.0000
Reconciled Depreciation
31,911.0000
36,498.0000
26,148.0000
20,246.0000
23,289.0000
Net Income from Continuing Operation Net Minority Interest
-521,968.0000
-311,656.0000
-217,490.0000
-183,619.0000
-250,863.0000
Total Unusual Items Excluding Goodwill
-207,168.0000
--
32,989.0000
--
-44,692.0000
Total Unusual Items
-207,168.0000
--
32,989.0000
--
-44,692.0000
Normalized EBITDA
-92,632.0000
-287,513.0000
-260,994.0000
-164,950.0000
-145,774.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
--
--
Tax Effect of Unusual Items
-229.1532
--
659.7800
--
--
3/31/2020 - 11/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GH Guardant Health, Inc.
25.52
+13.37%
 
ISPC iSpecimen Inc.
0.3079
+7.66%
 
ILMN Illumina, Inc.
106.48
+0.60%
 
DMTK DermTech, Inc.
0.3900
+6.53%
 
NTRA Natera, Inc.
109.51
+1.86%
 
EXAS Exact Sciences Corporation
49.84
-7.84%
 
OPK OPKO Health, Inc.
1.3600
+6.25%
 
PSNL Personalis, Inc.
1.3400
-6.94%
 
TWST Twist Bioscience Corporation
42.23
+2.10%
 
LMDXF LumiraDx Limited
0.0219
+36.87%